Tracking life and health to fund rare cancer drugs
NCT ID NCT04814095
Summary
This study aims to collect real-world information on how patients with rare cancers or rare genetic changes in their cancer fare when using approved targeted therapies. It will track survival, quality of life, and how well the treatment works. The goal is to gather strong evidence to help health authorities decide if these treatments should be publicly funded for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BC Cancer
RECRUITINGVancouver, British Columbia, V5Z4E6, Canada
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.